Trulieve Cannabis (TCNNF) Cash & Equivalents (2020 - 2026)

Trulieve Cannabis' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $352.9 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 7.44% year-over-year to $352.9 million; the TTM figure through Mar 2026 stood at $352.9 million (up 7.44% YoY), while the FY2025 annual figure was $255.5 million, up 7.01% from the prior year.
• Cash & Equivalents was $352.9 million for Q1 2026 at Trulieve Cannabis, up from $255.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $449.2 million in Q3 2025 to a low of $14.9 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $250.1 million across 5 years, with a median of $238.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents sank 94.86% in 2022, then soared 923.92% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $207.2 million in 2022, then slipped by 2.81% to $201.4 million in 2023, then grew by 18.59% to $238.8 million in 2024, then rose by 7.01% to $255.5 million in 2025, then surged by 38.09% to $352.9 million in 2026.
• The last three Cash & Equivalents figures came in at $352.9 million (Q1 2026), $255.5 million (Q4 2025), and $449.2 million (Q3 2025), per Business Quant data.